130 related articles for article (PubMed ID: 20427365)
1. Prostate cancer incidence trends in Spain before and during the prostate-specific antigen era: impact on mortality.
Larrañaga N; Galceran J; Ardanaz E; Franch P; Navarro C; Sánchez MJ; Pastor-Barriuso R;
Ann Oncol; 2010 May; 21 Suppl 3():iii83-89. PubMed ID: 20427365
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer incidence and mortality in Navarre (Spain).
Etxeberria J; Guevara M; Moreno-Iribas C; Burgui R; Delfrade I; Floristán Y; Montesino M; Ardanaz E
An Sist Sanit Navar; 2018 Apr; 41(1):9-15. PubMed ID: 29358783
[TBL] [Abstract][Full Text] [Related]
3. Differences in the epidemic rise and decrease of prostate cancer among geographical areas in Southern Europe. an analysis of differential trends in incidence and mortality in France, Italy and Spain.
Quaglia A; Parodi S; Grosclaude P; Martinez-Garcia C; Coebergh JW; Vercelli M
Eur J Cancer; 2003 Mar; 39(5):654-65. PubMed ID: 12628846
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer incidence and mortality trends among elderly and adult Europeans.
Vercelli M; Quaglia A; Marani E; Parodi S
Crit Rev Oncol Hematol; 2000 Aug; 35(2):133-44. PubMed ID: 10936470
[TBL] [Abstract][Full Text] [Related]
5. Changes in colorectal cancer incidence and mortality trends in Spain.
López-Abente G; Ardanaz E; Torrella-Ramos A; Mateos A; Delgado-Sanz C; Chirlaque MD;
Ann Oncol; 2010 May; 21 Suppl 3():iii76-82. PubMed ID: 20427364
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer incidence and mortality in Portugal: trends, projections and regional differences.
Pina F; Castro C; Ferro A; Bento MJ; Lunet N
Eur J Cancer Prev; 2017 Sep; 26(5):404-410. PubMed ID: 27483413
[TBL] [Abstract][Full Text] [Related]
7. Trends in net survival from prostate cancer in six European Latin countries: results from the SUDCAN population-based study.
Grosclaude P; Roche L; Fuentes-Raspall R; Larrañaga N;
Eur J Cancer Prev; 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study():S114-S120. PubMed ID: 28005614
[TBL] [Abstract][Full Text] [Related]
8. Incidence and mortality trends for prostate cancer in 5 French areas from 1982 to 1996.
Chirpaz E; Colonna M; Menegoz F; Grosclaude P; Schaffer P; Arveux P; Lesec'h JM; Exbrayat C; Schaerer R
Int J Cancer; 2002 Jan; 97(3):372-6. PubMed ID: 11774291
[TBL] [Abstract][Full Text] [Related]
9. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.
Kelly SP; Anderson WF; Rosenberg PS; Cook MB
Eur Urol Focus; 2018 Jan; 4(1):121-127. PubMed ID: 29162421
[TBL] [Abstract][Full Text] [Related]
10. Quebec prostate cancer mortality dropped in 1996.
Meyer F; Moore L; Bairati I; Fradet Y
Cancer Prev Control; 1998 Aug; 2(4):163-6. PubMed ID: 10093628
[TBL] [Abstract][Full Text] [Related]
11. Trends in incidence and mortality rates for prostate cancer before and after prostate-specific antigen introduction. A registry-based study in southeastern Netherlands, 1971-1995.
Post PN; Kil PJ; Crommelin MA; Schapers RF; Coebergh JW
Eur J Cancer; 1998 Apr; 34(5):705-9. PubMed ID: 9713278
[TBL] [Abstract][Full Text] [Related]
12. Trends in mortality rates in patients with prostate cancer during the era of prostate specific antigen screening.
Merrill RM; Stephenson RA
J Urol; 2000 Feb; 163(2):503-10. PubMed ID: 10647666
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer in Austria: impact of prostate-specific antigen test on incidence and mortality.
Vutuc C; Waldhoer T; Madersbacher S; Micksche M; Haidinger G
Eur J Cancer Prev; 2001 Oct; 10(5):425-8. PubMed ID: 11711757
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
[TBL] [Abstract][Full Text] [Related]
15. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts.
Helgstrand JT; Røder MA; Klemann N; Toft BG; Lichtensztajn DY; Brooks JD; Brasso K; Vainer B; Iversen P
Cancer; 2018 Jul; 124(14):2931-2938. PubMed ID: 29723398
[TBL] [Abstract][Full Text] [Related]
16. Breast and prostate cancer: an analysis of common epidemiological features in mortality trends in Spain.
López-Abente G; Mispireta S; Pollán M
BMC Cancer; 2014 Nov; 14():874. PubMed ID: 25421124
[TBL] [Abstract][Full Text] [Related]
17. Has prostate cancer mortality stopped its decline in Spain?
Cayuela A; Cayuela L; Ruiz-Romero MV; Rodríguez-Domínguez S; Lendínez-Cano G; Bachiller-Burgos J
Actas Urol Esp; 2015 Dec; 39(10):612-9. PubMed ID: 26166386
[TBL] [Abstract][Full Text] [Related]
18. Trends in stage-specific incidence of prostate cancer in Norway, 1980-2010: a population-based study.
Møller MH; Kristiansen IS; Beisland C; Rørvik J; Støvring H
BJU Int; 2016 Oct; 118(4):547-55. PubMed ID: 26497872
[TBL] [Abstract][Full Text] [Related]
19. Long-term trends in pancreatic cancer mortality in Spain (1952-2012).
Seoane-Mato D; Nuñez O; Fernández-de-Larrea N; Pérez-Gómez B; Pollán M; López-Abente G; Aragonés N
BMC Cancer; 2018 Jun; 18(1):625. PubMed ID: 29866063
[TBL] [Abstract][Full Text] [Related]
20. Recent incidence and surgery trends for prostate cancer: Towards an attenuation of overdiagnosis and overtreatment?
Jegerlehner S; Chiolero A; Aujesky D; Rodondi N; Germann S; Konzelmann I; Bulliard JL;
PLoS One; 2019; 14(2):e0210434. PubMed ID: 30716740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
